Pletal

This page contains recent news articles, when available, and an overview of Pletal but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

State ex rel. Kroger Co. Industrial Commission of Ohio  -  ‎Nov 4, 2009‎
He states he is currently taking Pletal, Norvasc, and aspirin therapy. According to the enclosed records, the allowed condition of this claim is hypothenar ... Leagle, Inc.

Pletal dopo terapia endovascolare nei pazienti con claudicatio ...  -  ‎Aug 19, 2009‎
Mercoledì 19 Agosto 2009 - Cilostazolo ( Pletal ) migliora la distanza a piedi nei pazienti con claudicatio intermittens e riduce la ristenosi dopo XagenaSalute

PAD prevalent among patients with diabetes, metabolic syndrome  -  ‎Jul 1, 2009‎
...a six-month program of supervised exercise vs. home exercise with use of cilostazol (Pletal, Otsuka Pharmaceuticals) in the treatment of claudication. Cardiology Today

Adiós al síndrome del escaparate  -  ‎Jun 19, 2009‎
El fármaco, que comercializa la empresa Otsuka Ferrer con el nombre de Pletal, lleva en el mercado desde los años ochenta, pero hasta ahora no se podía La Voz de Galicia

2014ë…„ 3ê°œ 항혈전제 블ë¡?버스터  -  ‎Apr 1, 2009‎
...다ì?Œìœ¼ë¡œ 기존 제품ì?¸ ‘프레탈’(Pletal, cilostazol)ì?˜ 매출ì?´ 2014년까지 ì—°í?‰ê·  6% 성장해 5ì–µ8500만달러, ‘액티ë?¼ì œâ€™(actilyse, alteplase)ê°€ 5ì–µ6900만달러 매출로 디지틀보사

GAZZETTA UFFICIALE: SOMMARIO (3)  -  ‎Mar 10, 2009‎
Variazione di tipo II, secondo procedura di mutuo riconoscimento, dell'autorizzazione all'immissione in commercio del medicinale per uso umano "Pletal". ANSA Valle d'Aosta

Peripheral arterial disease  -  Jan 21, 2009
One is called cilostazol (Pletal). It can cause headache, diarrhoea, heart flutters (palpitations) and dizziness. The other is pentoxifylline (Trental). guardian.co.uk,

The current pharmacological treatment options for Peripheral ...  -  Nov 9, 2008
Cilostazol (Pletal), an antiplatelet, is recommended as first-line therapy for claudication The new agents in development for PAD are primarily as secondary Live-PR.com (Pressemitteilung),

For Abbott, Boston stents, it's a draw  -  Oct 13, 2008
Five studies showed better results when the generic cilostazol--aka Pletal, from Otsuka Pharmaceuticals--was added to standard therapy with aspirin and the FiercePharma,

Peripheral artery disease is treatable  -  Oct 14, 2008
Pletal, Plavix and Trental are the names of some of those used for PAD. The same procedures used to unclog clogged heart arteries are used for leg arteries. St. Louis Post-Dispatch,

Genes to the rescue: Growing new vessels may save limbs  -  16 Sep 2008
Drugs such as Trental or Pletal may be used specifically for PAD, but they are of limited benefit, Mendelsohn said. "If (Trental) had to undergo FDA Belleville News Democrat,

Cilostazol found may be safer than aspirin post-stroke  -  May 4, 2008
Manufactured by Otsuka Pharmaceutical Co., cilostazol is known by its brand name Pletal. Stroke is the second leading cause of death in China, Reuters India,

Cilostazol as Effective as Aspirin in Prevention of Recurrent Stroke  -  May 9, 2008
May 8, 2008 — Results of a randomized pilot trial suggest that cilostazol (Pletal, Otsuka Pharmaceuticals), a phosphodiesterase 3 (PDE3) inhibitor, Medscape (subscription)





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy